Donor lymphocyte infusions for the treatment of chronic myelogenous leukaemia relapse following peripheral blood or bone marrow stem cell transplantation

被引：0
|
作者：
Basak, G. W.
de Wreede, L. C.
van Biezen, A.
Wiktor-Jedrzejczak, W.
Schmid, C.
Schattenberg, A.
Dazzi, F.
von dem Borne, P.
Petersen, E.
Beelen, D.
Abayomi, A.
Volin, L.
Buzyn, A.
Gurman, G.
Bunjes, D.
Olavarria, E.
de Witte, T.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S307 / S307
页数：1
相关论文
共 50 条
  • [1] Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation
    G W Basak
    L C de Wreede
    A van Biezen
    W Wiktor-Jedrzejczak
    K Halaburda
    C Schmid
    N Schaap
    F Dazzi
    P A von dem Borne
    E Petersen
    D Beelen
    A Abayomi
    L Volin
    A Buzyn
    G Gurman
    D Bunjes
    C Guglielmi
    E Olavarria
    T de Witte
    Bone Marrow Transplantation, 2013, 48 : 837 - 842
  • [2] Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation
    Basak, G. W.
    de Wreede, L. C.
    van Biezen, A.
    Wiktor-Jedrzejczak, W.
    Halaburda, K.
    Schmid, C.
    Schaap, N.
    Dazzi, F.
    von dem Borne, P. A.
    Petersen, E.
    Beelen, D.
    Abayomi, A.
    Volin, L.
    Buzyn, A.
    Gurman, G.
    Bunjes, D.
    Guglielmi, C.
    Olavarria, E.
    de Witte, T.
    BONE MARROW TRANSPLANTATION, 2013, 48 (06) : 837 - 842
  • [3] Donor lymphocyte infusions for relapse of chronic myelogenous leukemia after reduced intensity conditioning stem cell transplantation
    Basak, G. W.
    van Biezen, A.
    Brand, R.
    Szydlo, R.
    Schattenberg, A.
    Von Dem Borne, P. A.
    Kroger, N.
    Verdonck, L.
    Finke, J.
    Bunjes, D.
    Guglielmi, C.
    Wiktor-Jedrzejczak, W.
    Olavarria, E.
    de Witte, T.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S240 - S240
  • [4] Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions
    Cwynarski, K
    Goulding, R
    Pocock, C
    Dazzi, F
    Craddock, C
    Kaeda, J
    Olavarria, E
    Kanfer, E
    Apperley, J
    Lawler, M
    Goldman, JM
    BONE MARROW TRANSPLANTATION, 2001, 28 (06) : 581 - 586
  • [5] Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions
    K Cwynarski
    R Goulding
    C Pocock
    F Dazzi
    C Craddock
    J Kaeda
    E Olavarria
    E Kanfer
    J Apperley
    M Lawler
    JM Goldman
    Bone Marrow Transplantation, 2001, 28 : 581 - 586
  • [6] Donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukaemia
    Gilleece, MH
    Dazzi, F
    LEUKEMIA & LYMPHOMA, 2003, 44 (01) : 23 - 28
  • [7] Autologous peripheral blood haematopoietic stem cell transplantation for chronic myelogenous leukaemia
    Carella, AM
    Cavalierè, M
    Lerma, E
    Corsetti, MT
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 1999, 12 (1-2) : 209 - 217
  • [8] Bone marrow reticulin pattern in chronic myelogenous leukaemia following bone marrow transplantation
    Pillai, GJ
    Hasserjian, RP
    Szydlo, R
    Lampert, IA
    JOURNAL OF PATHOLOGY, 2001, 195 : 10A - 10A
  • [9] Risk of donor lymphocyte infusions following allogeneic bone marrow transplantation
    vanBekkum, DW
    KinwelBohre, EPM
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (06) : 478 - 480
  • [10] Toxicity and efficacy of 409 donor lymphocyte infusions for treatment of relapse after allogeneic bone marrow transplantation
    Raiola, AM
    Van Lint, MT
    Lamparelli, T
    Gualandi, F
    Di Grazia, C
    Dominietto, A
    Romagnani, C
    Berisso, G
    Bregante, S
    Vassallo, F
    Frassoni, F
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 2001, 27 : S127 - S127
12345